Stay Informed

News

All News Announcements Blog GHTC in the Media Advocacy Actions
Representatives Anna Eshoo and Mario Diaz-Balart and developers of the RTS,S malaria vaccine honored with GHTC Innovating for Impact Awards
November 13, 2019

Representatives Anna Eshoo and Mario Diaz-Balart and developers of the RTS,S malaria vaccine honored with GHTC Innovating for Impact Awards

GHTC yesterday honored Congresswoman Anna Eshoo (D-CA) and Congressman Mario Diaz-Balart (R-FL) for their leadership in supporting global health research and development (R&D) at its 2019 Innovating for Impact Awards, an initiative celebrating the US policymakers and partnerships driving global health innovation. GHTC also recognized the partnership that developed the RTS,S malaria vaccine—the world’s first malaria vaccine—for its efforts to advance this breakthrough technology.

Learn More
GHTC sends letter urging Congressional appropriators to include report language on BARDA in F20 bill
USAID
October 27, 2019

GHTC sends letter urging Congressional appropriators to include report language on BARDA in F20 bill

GHTC sent a letter to House and Senate appropriators urging them to include in the final fiscal year (FY) 2020 Labor, Health and Human Services, Education, and Related Agencies bill report language emphasizing the role of the Biomedical Advanced Research and Development Authority (BARDA) in advancing R&D for naturally-occurring health threats and requesting a delineation of BARDA’s investments in this area in its annual five-year budget plan. 

PDF
GHTC endorses letter calling for robust TB funding in FY20 appropriations bill
PATH/Ruhani Kaur
October 23, 2019

GHTC endorses letter calling for robust TB funding in FY20 appropriations bill

GHTC endorsed a letter from the TB Roundtable to House and Senate appropriators urging the adoption of robust funding levels for tuberculosis (TB) programs at the US Agency for International Development and Centers for Disease Control and Prevention in final fiscal year 2020 (FY20) appropriations bills. The letter also urges appropriators to restore TB as a disease eligible for funding under the Department of Defense’s Peer Reviewed Medical Research Program.

PDF
GHTC endorses letter urging robust funding for NIH in FY20 appropriations bill
National Institute of Allergy and Infectious Diseases, National Institutes of Health
October 23, 2019

GHTC endorses letter urging robust funding for NIH in FY20 appropriations bill

GHTC endorsed a letter from the Ad Hoc Group for Medical Research urging House and Senate appropriators to work quickly to adopt a meaningful increase to the fiscal year 2020 (FY20) Labor, Health and Human Services, Education, and Related Agencies appropriations bill and provide a robust funding increase for the National Institutes of Health.

PDF
GHTC responds to RFI on National Vaccine Action Plan
PATH/Gabe Bienczycki
October 23, 2019

GHTC responds to RFI on National Vaccine Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.

PDF
GHTC endorses STOP Neglected Diseases of Poverty Act
Flickr/Kent MacElwee
October 22, 2019

GHTC endorses STOP Neglected Diseases of Poverty Act

GHTC endorsed the STOP (Study, Treat, Observe, and Prevent) Neglected Diseases of Poverty Act, a piece of legislation introduced by Senator Cory Booker (D-NJ) aimed at advancing the tools necessary to address and ultimately eliminate neglected disease of poverty in the United States.

View